Recombinant Erythropoietin Drugs Market Report

China Recombinant Erythropoietin Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 08, 2023
  • PAGES：147
  • REPORT CODE：GMM1839436
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Erythropoietin Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sun Pharmaceutical Industries Ltd

    • 3SBio Group

    • Kyowa Hakko Kirin

    • Celltrion, Inc

    • Johnson & Johnson

    • Dr Reddy's Laboratories Ltd

    • LG Life Sciences Ltd

    • Roche

    • Amgen

    • Biocon Limited

    • Teva Pharmaceutical Industries Ltd

    By Type:

    • Erythropoiesis-Stimulating Agents (ESA)

    • rhEPO

    By Application:

    • Chronic Kidney Disease

    • Cancer Related Anemia

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant Erythropoietin Drugs Market Overview 2018-2029

    • 1.1 China Recombinant Erythropoietin Drugs Industry Development Overview

    • 1.2 China Recombinant Erythropoietin Drugs Industry Development History

    • 1.3 China Recombinant Erythropoietin Drugs Industry Market Size (2018-2029)

    • 1.4 China Recombinant Erythropoietin Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant Erythropoietin Drugs Production Volume, Production Value and Growth Rate of Erythropoiesis-Stimulating Agents (ESA) (2018-2029)

      • 1.4.2 China Recombinant Erythropoietin Drugs Production Volume, Production Value and Growth Rate of rhEPO (2018-2029)

    • 1.5 China Recombinant Erythropoietin Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant Erythropoietin Drugs Sales Volume, Sales Value and Growth Rate of Chronic Kidney Disease (2018-2029)

      • 1.5.2 China Recombinant Erythropoietin Drugs Sales Volume, Sales Value and Growth Rate of Cancer Related Anemia (2018-2029)

      • 1.5.3 China Recombinant Erythropoietin Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Recombinant Erythropoietin Drugs Market Analysis by Region

      • 1.6.1 North China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant Erythropoietin Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant Erythropoietin Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant Erythropoietin Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant Erythropoietin Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant Erythropoietin Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant Erythropoietin Drugs Industry Development

    Chapter 3 Recombinant Erythropoietin DrugsIndustry Chain Analysis

    • 3.1 Recombinant Erythropoietin Drugs Industry Chain

    • 3.2 Recombinant Erythropoietin Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant Erythropoietin Drugs Market

    • 3.3 Recombinant Erythropoietin Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant Erythropoietin Drugs Market

    Chapter 4 China Recombinant Erythropoietin Drugs Market, by Type

    • 4.1 China Recombinant Erythropoietin Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant Erythropoietin Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant Erythropoietin Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant Erythropoietin Drugs Production Volume and Growth Rate of Erythropoiesis-Stimulating Agents (ESA)

      • 4.5.2 China Recombinant Erythropoietin Drugs Production Volume and Growth Rate of rhEPO

    Chapter 5 China Recombinant Erythropoietin Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant Erythropoietin Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant Erythropoietin Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant Erythropoietin Drugs Market Size and Growth Rate of Chronic Kidney Disease

      • 5.5.2 China Recombinant Erythropoietin Drugs Market Size and Growth Rate of Cancer Related Anemia

      • 5.5.3 China Recombinant Erythropoietin Drugs Market Size and Growth Rate of Others

    Chapter 6 China Recombinant Erythropoietin Drugs Market, by Region

    • 6.1 China Recombinant Erythropoietin Drugs Production Volume and Production Value, by Region

    • 6.2 China Recombinant Erythropoietin Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant Erythropoietin Drugs Market Analysis

    • 7.1 North China Recombinant Erythropoietin Drugs Market, by Type

    • 7.2 North China Recombinant Erythropoietin Drugs Market, by Application

    Chapter 8 Central China Recombinant Erythropoietin Drugs Market Analysis

    • 8.1 Central China Recombinant Erythropoietin Drugs Market, by Type

    • 8.2 Central China Recombinant Erythropoietin Drugs Market, by Application

    Chapter 9 South China Recombinant Erythropoietin Drugs Market Analysis

    • 9.1 South China Recombinant Erythropoietin Drugs Market, by Type

    • 9.2 South China Recombinant Erythropoietin Drugs Market, by Application

    Chapter 10 East China Recombinant Erythropoietin Drugs Market Analysis

    • 10.1 East China Recombinant Erythropoietin Drugs Market, by Type

    • 10.2 East China Recombinant Erythropoietin Drugs Market, by Application

    Chapter 11 Northeast China Recombinant Erythropoietin Drugs Market Analysis

    • 11.1 Northeast China Recombinant Erythropoietin Drugs Market, by Type

    • 11.2 Northeast China Recombinant Erythropoietin Drugs Market, by Application

    Chapter 12 Southwest China Recombinant Erythropoietin Drugs Market Analysis

    • 12.1 Southwest China Recombinant Erythropoietin Drugs Market, by Type

    • 12.2 Southwest China Recombinant Erythropoietin Drugs Market, by Application

    Chapter 13 Northwest China Recombinant Erythropoietin Drugs Market Analysis

    • 13.1 Northwest China Recombinant Erythropoietin Drugs Market, by Type

    • 13.2 Northwest China Recombinant Erythropoietin Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sun Pharmaceutical Industries Ltd

        • 14.1.1 Sun Pharmaceutical Industries Ltd Company Profile

        • 14.1.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 3SBio Group

        • 14.2.1 3SBio Group Company Profile

        • 14.2.2 3SBio Group Recombinant Erythropoietin Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Kyowa Hakko Kirin

        • 14.3.1 Kyowa Hakko Kirin Company Profile

        • 14.3.2 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Celltrion, Inc

        • 14.4.1 Celltrion, Inc Company Profile

        • 14.4.2 Celltrion, Inc Recombinant Erythropoietin Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Johnson & Johnson

        • 14.5.1 Johnson & Johnson Company Profile

        • 14.5.2 Johnson & Johnson Recombinant Erythropoietin Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Dr Reddy's Laboratories Ltd

        • 14.6.1 Dr Reddy's Laboratories Ltd Company Profile

        • 14.6.2 Dr Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 LG Life Sciences Ltd

        • 14.7.1 LG Life Sciences Ltd Company Profile

        • 14.7.2 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Roche

        • 14.8.1 Roche Company Profile

        • 14.8.2 Roche Recombinant Erythropoietin Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Amgen

        • 14.9.1 Amgen Company Profile

        • 14.9.2 Amgen Recombinant Erythropoietin Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Biocon Limited

        • 14.10.1 Biocon Limited Company Profile

        • 14.10.2 Biocon Limited Recombinant Erythropoietin Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Teva Pharmaceutical Industries Ltd

        • 14.11.1 Teva Pharmaceutical Industries Ltd Company Profile

        • 14.11.2 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant Erythropoietin Drugs Industry Research Conclusions

    • 15.2 Recombinant Erythropoietin Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant Erythropoietin Drugs Industry Market Size (2018-2029)

    • Figure China Recombinant Erythropoietin Drugs Production Volume, Production Value and Growth Rate of Erythropoiesis-Stimulating Agents (ESA) (2018-2029)

    • Figure China Recombinant Erythropoietin Drugs Production Volume, Production Value and Growth Rate of rhEPO (2018-2029)

    • Figure China Recombinant Erythropoietin Drugs Sales Volume, Sales Value and Growth Rate of Chronic Kidney Disease (2018-2029)

    • Figure China Recombinant Erythropoietin Drugs Sales Volume, Sales Value and Growth Rate of Cancer Related Anemia (2018-2029)

    • Figure China Recombinant Erythropoietin Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant Erythropoietin Drugs Market Size and Growth Rate from 2018-2029

    • Figure Recombinant Erythropoietin Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant Erythropoietin Drugs Market Share by Type in 2018

    • Figure China Recombinant Erythropoietin Drugs Market Share by Type in 2023

    • Figure China Recombinant Erythropoietin Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Production Volume and Growth Rate of Erythropoiesis-Stimulating Agents (ESA) (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Production Volume and Growth Rate of rhEPO (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Market Share by Application in 2018

    • Figure China Recombinant Erythropoietin Drugs Market Share by Application in 2023

    • Figure China Recombinant Erythropoietin Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant Erythropoietin Drugs Market Size and Growth Rate of Chronic Kidney Disease (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Market Size and Growth Rate of Cancer Related Anemia (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Market Size and Growth Rate of Others (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Production Volume by Region (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Production Volume Share by Region (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Production Volume Share by Region (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Production Value by Region (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Production Value Share by Region (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Production Value Share by Region (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Sales Volume by Region (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Sales Volume Share by Region (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Sales Value by Region (2018-2023)

    • Table China Recombinant Erythropoietin Drugs Sales Value Share by Region (2018-2023)

    • Figure China Recombinant Erythropoietin Drugs Sales Value Share by Region (2018-2023)

    • Table North China Recombinant Erythropoietin Drugs Production Volume by Type (2018-2023)

    • Table North China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Table North China Recombinant Erythropoietin Drugs Sales Volume by Application (2018-2023)

    • Table North China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant Erythropoietin Drugs Production Volume by Type (2018-2023)

    • Table Central China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant Erythropoietin Drugs Sales Volume by Application (2018-2023)

    • Table Central China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant Erythropoietin Drugs Production Volume by Type (2018-2023)

    • Table South China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Table South China Recombinant Erythropoietin Drugs Sales Volume by Application (2018-2023)

    • Table South China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant Erythropoietin Drugs Production Volume by Type (2018-2023)

    • Table East China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Table East China Recombinant Erythropoietin Drugs Sales Volume by Application (2018-2023)

    • Table East China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant Erythropoietin Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant Erythropoietin Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant Erythropoietin Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant Erythropoietin Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant Erythropoietin Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant Erythropoietin Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant Erythropoietin Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant Erythropoietin Drugs Sales Volume Share by Application (2018-2023)

    • Table Sun Pharmaceutical Industries Ltd Company Profile

    • Table Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table 3SBio Group Company Profile

    • Table 3SBio Group Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Kyowa Hakko Kirin Company Profile

    • Table Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Celltrion, Inc Company Profile

    • Table Celltrion, Inc Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Dr Reddy's Laboratories Ltd Company Profile

    • Table Dr Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table LG Life Sciences Ltd Company Profile

    • Table LG Life Sciences Ltd Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Biocon Limited Company Profile

    • Table Biocon Limited Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd Company Profile

    • Table Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US